Lymph Cancer Testing Market Statistical Forecast, Trade Analysis 2024 -2031 - Siemens Healthineers, Abbott Laboratories & Agilent Technologies.

The Global Lymph Cancer Testing Market was valued at $8.5 billion in 2023 and is projected to grow to $19.63 billion by 2031. This growth represents a CAGR of 11.3% from 2024 to 2031.

Lymphoma is a type of blood cancer that impacts the immune system by affecting white blood cells known as lymphocytes. These cells are crucial for immune function, but in lymphoma, they grow uncontrollably and malfunction. Lymphoma, also referred to as lymphatic cancer, disrupts the normal development and function of lymphocytes.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/lymph-cancer-testing-market

Market Dynamics:

Increasing prevalence of lymph cancers

The global lymph cancer testing market is expanding due to several key factors, notably the rising prevalence of lymph cancers.

According to the American Cancer Society, non-Hodgkin lymphoma (NHL) is among the most common cancers in the U.S., representing about 4% of all cancer cases. In 2024, an estimated 80,620 individuals, including both adults and children, are expected to be diagnosed with NHL. Of these, approximately 20,140 will die from the disease. The lifetime risk of developing NHL is roughly 1 in 42 for men and 1 in 52 for women. While NHL can affect people at any age, it is particularly prevalent among children, teens, and young adults, with over half of those diagnosed being 65 or older.

Market Segmentation:

By Test Type: Sentinel lymph node Biopsy, Blood Tests, CT Scan & PET Scan, Others.

By Disease Type: Non-Hodgkin Lymphoma, Hodgkin Lymphoma.

By End-User: Hospitals, Diagnostic Centers, Research and Educational Institutions, Others.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/lymph-cancer-testing-market

Competitive Landscape:

• GE Healthcare
• Siemens Healthineers
• Abbott Laboratories
• Canon Medical Systems
• Agilent Technologies
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry genetics
• Bio-Rad Laboratories

Regional Analysis:

The global Lymph Cancer Testing Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Lymph Cancer Testing Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Kidney Stone Management Devices Market: https://datamintelligence.com/research-report/kidney-stone-management-devices-market

Capnography Devices Market: https://datamintelligence.com/research-report/capnography-devices-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.